A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

NCT02688491 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Renal Neoplasms
Targeted Molecular Therapy

Interventions

DRUG: sunitinib

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]